Growth Investing

It Seems There’s No Bad Time to Invest

68 years of S&P 500 data shows long-term returns stay strong—even when buying at market highs. Here's why timing isn't everything.

Ulta Beauty Stock (ULTA): Strong Q2 Performance Highlights

Ulta beat Q2 expectations and raised guidance, yet shares fell 7%—here’s what retail investors need to know now.

Telomir Pharma Stock Soars 35% on Epigenetic Therapy Breakthrough

Telomir Pharmaceuticals surged after new data showed its lead drug could reset disease drivers, sparking investor buzz in a high-risk biotech play.

nCino Stock (NCNO): Robust Earnings Fuel Growth Prospects

nCino reported a 12% revenue increase in Q2 FY2026, boosted by strategic growth and strong mortgage volumes.

LegalZoom Stock (LZ): Growth Continues as Margins Improve

LegalZoom's Q2 CY2025 revenue reached $192.5 million, surpassing expectations, with strong cash flow and improved profitability metrics.

nLIGHT Stock (LASR): Q2 Growth and Profitability Outlook

nLIGHT posts a strong Q2 2025 with $61.7M in revenue and 49% growth in Aerospace sales, turning EPS positive and signaling a potential long-term rebound.

Salesforce Stock (CRM): Major Investments in AI Solutions

Salesforce and ServiceNow invest $1.5 billion in Genesys, strengthening AI capabilities in customer service software.

Solaris Energy Infrastructure Stock (SEI): Strong Growth Outlook

Solaris Energy Infrastructure (SEI) has surged over 130% this year, reflecting strong revenue momentum and solid earnings growth.

Vicor Stock (VICR): Strong Growth Prospects Amid Risk

Vicor's stock surges post-blockbuster Q2, with growth potential, but a lofty valuation is a concern for cautious investors.

GitLab Stock (GTLB): A Tech Growth Play

GitLab's stock rebounds as analysts remain bullish amid robust growth.

Centrus Energy Stock (LEU): Driving Energy Innovation

Centrus Energy has surged to record highs due to key contract extensions and positive market sentiment around HALEU production.

Applied Digital Stock (APLD): Growth Potential Amid Risks

Applied Digital's stock has surged 17% recently, boosted by major lease agreements and potential cost savings.

Nextracker Stock (NXT): Strong Growth and Analyst Support

Nextracker rebounds to $63 with strong fundamentals and bullish analyst support.

Charted: Risk vs Reward of the Top 20 High-Growth Platform Stocks

Explore the top 20 high-growth platform stocks with a clear risk vs reward heatmap for retail investors in 2025.

ProKidney Stock (PROK): Is the Hype Justified?

ProKidney's stock soared after promising Phase 2 trial results, highlighting the potential but also the risks in biotech investments.